2.1 Consolidated income statement

2.1 Consolidated income statement

For the year ended 31 December

 

 

 

€ million

Note

2019

2018

Continuing operations

 

 

 

Net Sales

5

4 680

4 412

Royalty income and fees

 

78

92

Other revenue

9

155

128

Revenue

 

4 913

4 632

Cost of sales

 

−1 268

−1 198

Gross profit

 

3 645

3 434

Marketing and selling expenses

 

−1 108

−964

Research and development expenses

 

−1 272

−1 161

General and administrative expenses

 

−195

−180

Other operating income/expenses (−)

12

48

−24

Operating profit before impairment, restructuring
and other income and expenses

 

1 118

1 105

Impairment of non-financial assets

13

−2

0

Restructuring expenses

14

−47

−20

Other income/expenses (−)

15

−1

24

Operating profit

 

1 068

1 109

Financial income

16

18

16

Financial expenses

16

−125

−109

Share of loss of associates

 

−1

−1

Profit before income taxes

 

960

1 015

Income tax expense

17

−146

−200

Profit from continuing operations

 

814

815

Discontinued operations

 

 

 

Profit/loss (−) from discontinued operations

8

2

8

Profit

 

817

823

Attributable to:

 

 

 

Equity holders of UCB SA

 

792

800

Non-controlling interests

 

25

23

Basic earnings per share (€)

 

 

 

from continuing operations

40

4.22

4.20

from discontinued operations

40

0.01

0.04

Total basic earnings per share

 

4.23

4.24

Diluted earnings per share (€)

 

 

 

from continuing operations

40

4.22

4.20

from discontinued operations

40

0.01

0.04

Total diluted earnings per share

 

4.23

4.24